Chiome Bioscience (TSE:4583) Common Stock : 円341.5 Mil (As of Jun. 2024)

View and export this data going back to 2011. Start your Free Trial

What is Chiome Bioscience Common Stock?

Chiome Bioscience's quarterly common stock increased from Dec. 2023 (円2,388.4 Mil) to Mar. 2024 (円2,587.8 Mil) but then declined from Mar. 2024 (円2,587.8 Mil) to Jun. 2024 (円341.5 Mil).

Chiome Bioscience's annual common stock increased from Dec. 2021 (円1,515.9 Mil) to Dec. 2022 (円2,097.0 Mil) and increased from Dec. 2022 (円2,097.0 Mil) to Dec. 2023 (円2,388.4 Mil).

Chiome Bioscience Common Stock Historical Data

The historical data trend for Chiome Bioscience's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Chiome Bioscience Common Stock Chart

Chiome Bioscience Annual Data

Trend

Mar14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Common Stock

Get a 7-Day Free Trial

6,132.22

1,387.68

1,515.93

2,097.02

2,388.42

Chiome Bioscience Quarterly Data
	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24
Common Stock	Get a 7-Day Free Trial															2,106.25	2,262.12	2,388.42	2,587.75	341.50

Chiome Bioscience Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

Chiome Bioscience Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Chiome Bioscience Inc (TSE:4583) » Definitions » Common Stock

Comparable Companies

Traded in Other Exchanges

N/A

Address

Sumitomo Fudosan Nishi-shinjuku Building No.6, 3-12-1, Honmachi, Shibuya-ku, Tokyo, JPN, 151-0071

Website

http://www.chiome.co.jp

Chiome Bioscience Inc is a Japanese based company engaged in the manufacture and sale of antibody drugs through the Autonomous Diversifying Library System. The business activity of the group is operated through Drug Discovery Alliance, Lead Antibody Licensing, and Licensing Out Platform Technology segments. The Drug Discovery Alliance segment partners with pharmaceutical companies to develop and create lead antibody drugs. The Lead Antibody Licensing Out segment is engaged in the production of specific antibodies against antigens and early licensing out to pharmaceutical manufacturers and the Licensing Out Platform Technology segment conducts research and development through the ADLib System. Geographically all the activities are functioned through Japan.

Chiome Bioscience Headlines

No Headlines